GOGL
Golden Ocean Group Ltd$19.89 −0.47 (−2.31%)
Oct 26 4:00 PM ET · prev $20.36
Since first trade
−17.2%
from $24.01 · Jun 26
30 days
−15.2%
from $23.45
Range since listing
$19.89–29.24
at the low
Avg volume 20D
8.9K
Oct 21 spike 24.8K
Short interest
🔒 Subscribers only
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest jumps 302.9% to 1.2K
- X Aug 14 Short interest jumps 1423.4% to 18.8K
- X Sep 15 Short interest falls 31.9% to 11.9K
Signal stack
Where each data set points today.
- TrendDOWNTREND
15% below its 50-day average. New closing low $19.89 on Oct 26.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 23, 2026 Event
Pazopanib
WARNING: HEPATOTOXICITY Severe and fatal hepatotoxicity has been observed in clinical trials. Monito
Feb 27, 2026 Earnings calendar
GOGL Q4 2025 Earnings Before Market Open — 2026-02-27
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 19, 2026
Clinical Trial
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
Phase 2 · COMPLETED
Sep 23, 2026
FDA
Pazopanib
WARNING: HEPATOTOXICITY Severe and fatal hepatotoxicity has been observed in clinical trials. Monitor hepatic function and interrupt, reduce, or disco
Sep 9, 2026
FDA
Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.
Class II: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Aug 26, 2026
FDA
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Class II: CGMP deviations: tablets with black specks.
Aug 26, 2026
FDA
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Class II: CGMP deviations: tablets with black specks.
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short